Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005763
Filing Date
2016-05-10
Accepted
2016-05-10 10:32:50
Documents
59
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eglt-20160331x10q.htm 10-Q 1254593
2 EX-31.1 eglt-20160331ex311a6b124.htm EX-31.1 16647
3 EX-31.2 eglt-20160331ex312950f61.htm EX-31.2 16948
4 EX-32.1 eglt-20160331ex321832109.htm EX-32.1 8909
5 EX-32.2 eglt-20160331ex322a32094.htm EX-32.2 8429
  Complete submission text file 0001558370-16-005763.txt   6154354

Data Files

Seq Description Document Type Size
6 EX-101.INS eglt-20160331.xml EX-101.INS 1353684
7 EX-101.SCH eglt-20160331.xsd EX-101.SCH 48450
8 EX-101.CAL eglt-20160331_cal.xml EX-101.CAL 62091
9 EX-101.DEF eglt-20160331_def.xml EX-101.DEF 187260
10 EX-101.LAB eglt-20160331_lab.xml EX-101.LAB 481646
11 EX-101.PRE eglt-20160331_pre.xml EX-101.PRE 333869
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 161634112
SIC: 2834 Pharmaceutical Preparations